Does Glycine max leaves or Garcinia Cambogia promote weight-loss or lower plasma cholesterol in overweight individuals: A randomized control trial

Nutrition Journal

Volumn 10, Issue 1, 2011, Pages

  Kim, Ji Eun ^a   Jeon, Seon Min ^a   Park, Ki ^b   Lee, Woo ^c   Jeong, Tae Sook ^c   McGregor, Robin A ^a   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

atherosclerosis; cholesterol; clinical trial; hydroxyl citric acid; soybean leaves; weight loss

Indexed keywords

ADIPOCYTOKINE; ANTIOXIDANT; GARCINIA CAMBOGIA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; TRIACYLGLYCEROL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; LIPID; PLANT EXTRACT;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BLOOD TOXICITY; BODY COMPOSITION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; GARCINIA CAMBOGIA; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUTRITIONAL ASSESSMENT; OBESITY; PLANT LEAF; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SOYBEAN; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; BLOOD; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; METABOLISM;

ANIMALIA; GARCINIA CAMBOGIA; GLYCINE MAX;

ADIPOKINES; ALANINE TRANSAMINASE; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CHOLESTEROL; DIETARY SUPPLEMENTS; FEMALE; GARCINIA CAMBOGIA; HUMANS; LIPIDS; MALE; OVERWEIGHT; PLANT EXTRACTS; PLANT LEAVES; SOYBEANS; WEIGHT LOSS;

EID: 80053175452     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-10-94     Document Type: Article

References (51)

1. Body-mass index and mortality in a prospective cohort of U.S. adults. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW, N Engl J Med 1999 341 1097 1105 10.1056/NEJM199910073411501 10511607 (Pubitemid 29466221)
2. Obesity as a medical problem. Kopelman PG, Nature 2000 404 635 643 10766250 (Pubitemid 30205068)
3. Long-term weight loss effects on all cause mortality in overweight/obese populations. Poobalan AS, Aucott LS, Smith WCS, Avenell A, Jung R, Broom J, Obes Rev 2007 8 503 513 10.1111/j.1467-789X.2007.00393.x 17949355 (Pubitemid 47628490)
4. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Grundy SM, Cleeman JI, Bairey Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ, J Am Coll Cardiol 2004 44 720 732 10.1016/j.jacc.2004.07.001 15358046
5. Dietary supplements for body-weight reduction: a systematic review. Pittler MH, Ernst E, Am J Clin Nutr 2004 79 529 536 15051593 (Pubitemid 41103893)
6. An evidence-based review of fat modifying supplemental weight loss products. Egras AM, Hamilton WR, Lenz TL, Monaghan MS, J Obes 2011 2011
7. Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. Dewell A, Hollenbeck PLW, Hollenbeck CB, J Clin Endocrinol Metab 2006 91 772 780 16384855 (Pubitemid 43357735)
8. Soy, phytoestrogens and metabolism: A review. Cederroth CR, Nef S, Mol Cell Endocrinol 2009 304 30 42 10.1016/j.mce.2009.02.027 19433245
9. Insights gained from 20 years of soy research. Messina M, J Nutr 2010 140 2289S 2295S 10.3945/jn.110.124107 20980639
10. Nutraceuticals and atherosclerosis: human trials. Badimon L, Vilahur G, Padro T, Cardiovasc Ther 2010 28 202 215 10.1111/j.1755-5922.2010.00189.x 20633023
11. The potential role of soyfoods in weight and adiposity reduction: an evidence-based review. Cope MB, Erdman JW, Allison DB, Obes Rev 2008 9 219 235 10.1111/j.1467-789X.2007.00390.x 18419671 (Pubitemid 351559565)
12. Difference in flavonoid and isoflavone profile between soybean and soy leaf. Ho HM, Chen RY, Leung LK, Chan FL, Huang Y, Chen Z-Y, Biomed Pharmacother 2002 56 289 295 12224600 (Pubitemid 35245312)
13. The most abundant polyphenol of soy leaves, coumestrol, displays potent [alpha]-glucosidase inhibitory activity. Yuk HJ, Lee JH, Curtis-Long MJ, Lee JW, Kim YS, Ryu HW, Park CG, Jeong T-S, Park KH, Food Chem 2011 126 1057 1063 10.1016/j.foodchem.2010.11.125
14. The Use of Garcinia Extract (Hydroxycitric Acid) as a Weight loss Supplement: A Systematic Review and Meta-Analysis of Randomised Clinical Trials. Onakpoya I, Hung SK, Perry R, Wider B, Ernst E, J Obes 2011 2011 509038 21197150
15. Effects of (-)-hydroxycitric acid on appetitive variables. Mattes RD, Bormann L, Physiol Behav 2000 71 87 94 10.1016/S0031-9384(00)00321-8 11134690 (Pubitemid 32008108)
16. Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Ohia SE, Opere CA, LeDay AM, Bagchi M, Bagchi D, Stohs SJ, Mol Cell Biochem 2002 238 89 103 10.1023/A:1019911205672 12349913 (Pubitemid 35023532)
17. Transcriptome of primary adipocytes from obese women in response to a novel hydroxycitric acid-based dietary supplement. Roy S, Shah H, Rink C, Khanna S, Bagchi D, Bagchi M, Sen CK, DNA Cell Biol 2007 26 627 639 10.1089/dna.2007.0617 17708719
18. Effects of garcinol and guttiferone K isolated from Garcinia cambogia on oxidative/nitrative modifications in blood platelets and plasma. Kolodziejczyk J, Masullo M, Olas B, Piacente S, Wachowicz B, Platelets 2009 20 487 492 10.3109/09537100903165182 19852687
19. Protective effect of Garcinia against renal oxidative stress and biomarkers induced by high fat and sucrose diet. Amin KA, Kamel HH, Abd Eltawab MA, Lipids Health Dis 2011 10 6 10.1186/1476-511X-10-6 21235803
20. Reduction of adipose tissue and body weight: effect of water soluble calcium hydroxycitrate in Garcinia atroviridis on the short term treatment of obese women in Thailand. Roongpisuthipong C, Kantawan R, Roongpisuthipong W, Asia Pac J Clin Nutr 2007 16 25 29 17215177 (Pubitemid 46280354)
21. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C, JAMA 1998 280 1596 1600 10.1001/jama.280.18.1596 9820262 (Pubitemid 28520648)
22. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. WHO expert consultation, The Lancet 2004 363 157 163
23. Validation of tetrapolar bioelectrical impedance method to assess human body composition. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA, J Appl Physiol 1986 60 1327 1332 3700310 (Pubitemid 16028434)
24. Bioelectrical impedance analysis - part II: utilization in clinical practice. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gámez J, Lilienthal Heitmann B, Kent-Smith L, Melchior J-C, Pirlich M, Scharfetter H, M.W.J Schols A, Pichard C, Clin Nutr 2004 23 1430 1453 10.1016/j.clnu.2004.09.012 15556267 (Pubitemid 39517638)
25. Dietary restraint and disinhibition do not affect accuracy of 24-hour recall in a multiethnic population. Ard JD, Desmond RA, Allison DB, Conway JM, J Am Diet Assoc 2006 106 434 437 10.1016/j.jada.2005.12.006 16503235 (Pubitemid 43288022)
26. Validation of energy intake measurements determined from observer-recorded food records and recall methods compared with the doubly labeled water method in overweight and obese individuals. Hise ME, Sullivan DK, Jacobsen DJ, Johnson SL, Donnelly JE, Am J Clin Nutr 2002 75 263 267 11815316 (Pubitemid 34101210)
27. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Marklund S, Marklund G, Eur J Biochem 1974 47 469 474 10.1111/j.1432-1033.1974.tb03714.x 4215654
28. Aebi H, Catalase Bergmeyer, H. New York: Academic Press 1986
29. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Paglia DE, Valentine WN, J Lab Clin Med 1967 70 158 169 6066618
30. Chemistry of the 2-thiobarbituric acid test for determination of oxidative rancidity in foods. II. - formation of the tba-malonaldehyde complex without acid-heat treatment. Tarladgis BG, Pearson AM, Jun LRD, J Sci Food Agric 1964 15 602 607 10.1002/jsfa.2740150904
31. Bioelectrical impedance analysis - part I: review of principles and methods. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gámez JM, Heitmann BL, Kent-Smith L, Melchior J-C, Pirlich M, Scharfetter H, Schols AMWJ, Pichard C, Clin Nutr 2004 23 1226 1243 10.1016/j.clnu.2004.06.004 15380917 (Pubitemid 39243041)
32. Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean beta-conglycinin. Kohno M, Hirotsuka M, Kito M, Matsuzawa Y, J Atheroscler Thromb 2006 13 247 255 10.5551/jat.13.247 17146153
33. Varying the protein source in mixed meal modifies glucose, insulin and glucagon kinetics in healthy men, has weak effects on subjective satiety and fails to affect food intake. Lang V, Bellisle F, Alamowitch C, Craplet C, Bornet FR, Slama G, Guy-Grand B, Eur J Clin Nutr 1999 53 959 965 10.1038/sj.ejcn. 1600881 10602354
34. Minimizing random error in dietary intakes assessed by 24-h recall, in overweight and obese adults. Jackson KA, Byrne NM, Magarey AM, Hills AP, Eur J Clin Nutr 2008 62 537 543 10.1038/sj.ejcn.1602740 17375109
35. Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient. Watts GF, Karpe F, Heart 2011 97 350 356 10.1136/hrt.2010.204990 21296781
36. The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? Vergeer M, Holleboom AG, Kastelein JJP, Kuivenhoven JA, J Lipid Res 2010 51 2058 2073 10.1194/jlr.R001610 20371550
37. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Sacks FM, Am J Cardiol 2002 90 139 143 10.1016/S0002-9149(02)02436-0 12106843 (Pubitemid 34775122)
38. The current state of serum biomarkers of hepatotoxicity. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S, Toxicology 2008 245 194 205 10.1016/j.tox.2007.11.021 18291570
39. Which Sources of Flavonoids: Complex Diets or Dietary Supplements? Egert S, Rimbach G, Adv Nutr 2011 2 8 14
40. Effect of free or protein-associated soy isoflavones on the antioxidant status in rats. Barbosa AC, Lajolo FM, Genovese MI, J Sci Food Agric 2011 91 721 731 10.1002/jsfa.4242 21302327
41. The in vivo antioxidant activity of soybean isoflavones in human subjects. Fritz KL, Seppanen CM, Kurzer MS, Saari Csallany A, Nutr Res 2003 23 479 487 10.1016/S0271-5317(03)00005-8 (Pubitemid 36535133)
42. Intake of dietary phytoestrogen and indices of antioxidant and bone metabolism of pre- and post-menopausal Korean women. Jang J-H, Yoon J-Y, Cho S-H, Nutr Res Pract 2007 1 305 312 10.4162/nrp.2007.1.4.305 20368955
43. Obesity, inflammation, and atherosclerosis. Rocha VZ, Libby P, Nat Rev Cardiol 2009 6 399 409 10.1038/nrcardio.2009.55 19399028
44. Adiposity Measures and Oxidative Stress Among Police Officers. Charles LE, Burchfiel CM, Violanti JM, Fekedulegn D, Slaven JE, Browne RW, Hartley TA, Andrew ME, Obesity 2008 16 2489 2497 10.1038/oby.2008.395 18719659
45. Adipocytokines: a bridge connecting obesity and insulin resistance. Zhuang X-F, Zhao M-M, Weng C-L, Sun N-L, Med Hypotheses 2009 73 981 985 10.1016/j.mehy.2009.05.036 19692185
46. Menstrual cycle effect on plasma lipids. Jones DY, Judd JT, Taylor PR, Campbell WS, Nair PP, Metabolism 1988 37 1 2 3277013 (Pubitemid 18057187)
47. Is equol the key to the efficacy of soy foods? Lampe JW, Am J Clin Nutr 2009 89 1664S 1667S 10.3945/ajcn.2009.26736T 19357217
48. Analytical and compositional aspects of isoflavones in food and their biological effects. Mortensen A, Kulling SE, Schwartz H, Rowland I, Ruefer CE, Rimbach G, Cassidy A, Magee P, Millar J, Hall WL, Kramer Birkved F, Sorensen IK, Sontag G, Mol Nutr Food Res 2009 53 266 309 10.1002/mnfr.200800478 19774555
49. Gas chromatography/mass spectrometry method to quantify blood hydroxycitrate concentration. Loe YC, Bergeron N, Rodriguez N, Schwarz JM, Anal Biochem 2001 292 148 154 10.1006/abio.2001.5046 11319829 (Pubitemid 32417733)
50. Regression towards the mean. Bland JM, Altman DG, BMJ 1994 308 1499 1499 8019287
51. Nutraceutical antioxidants for vascular protection? Please mind regression toward the mean. Fadini GP, Atherosclerosis 2011 215 30 31 10.1016/j.atherosclerosis.2010.11.040 21186026